Membrane topology for human vitamin K epoxide reductase

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2014-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/jth.12450PMID 24406068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the management of hemophilia

  2013cited by this paper
• Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces.

  2013cited by this paper
• Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A

  2013cited by this paper
• Human Vitamin K Epoxide Reductase and Its Bacterial Homologue Have Different Membrane Topologies and Reaction Mechanisms*♦

  2012cited by this paper
• DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype

  2012cited by this paper
• A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle.

  2011cited by this paper
• Mild haemophilia: a disease with many faces and many unexpected pitfalls

  2010cited by this paper
• Identification of VKORC1 interaction partners by split-ubiquitin system and coimmunoprecipitation

  2010cited by this paper
• Structure of a bacterial homolog of vitamin K epoxide reductase

  2010cited by this paper
• Detecting species-site dependencies in large multiple sequence alignments

  2009cited by this paper
• Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders

  2008cited by this paper
• Identification of the gene for vitamin K epoxide reductase

  2004cited by this paper
• Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

  2004cited by this paper
• Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)

  2003cited by this paper
• Desmopressin in Mild Hemophilia A: Indications, Limitations, Efficacy, and Safety

  2003cited by this paper
• Motifs of serine and threonine can drive association of transmembrane helices.

  2002cited by this paper
• How Membranes Shape Protein Structure*

  2001cited by this paper
• VMD: visual molecular dynamics.

  1996cited by this paper
• Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.

  1985cited by this paper

• From microtubule remodeling to clinical translation: the multifaceted roles of vasohibin-1 in disease modulation.

  2026cites this paper
• Structural Insights into Phylloquinone (Vitamin K1), Menaquinone (MK4, MK7), and Menadione (Vitamin K3) Binding to VKORC1

  2019cites this paper
• Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition.

  2018cites this paper
• Identification of the functional states of human vitamin K epoxide reductase from molecular dynamics simulations

  2017cites this paper
• Vitamin K epoxide reductase and its paralogous enzyme have different structures and functions

  2017cites this paper
• Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism.

  2017cites this paper
• VKORC1 et résistance aux antivitamines K : étude par modélisation moléculaire

  2017cites this paper
• The stability of the three transmembrane and the four transmembrane human vitamin K epoxide reductase models

  2016cites this paper
• Structural and functional insights into enzymes of the vitamin K cycle

  2016cites this paper
• Structural Modeling Insights into Human VKORC1 Phenotypes

  2015cites this paper
• The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif.

  2014cites this paper
• Desmopressin response in hemophilia A patients with FVIII:C < 0.10 IU mL−1

  2014cites this paper